BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6643682)

  • 1. Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years.
    Boers GH; Smals AG; Trijbels FJ; Leermakers AI; Kloppenborg PW
    J Clin Invest; 1983 Dec; 72(6):1971-6. PubMed ID: 6643682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridoxine treatment does not prevent homocystinemia after methionine loading in adult homocystinuria patients.
    Boers GH; Smals AG; Drayer JI; Trijbels FJ; Leermakers AI; Kloppenborg PW
    Metabolism; 1983 Apr; 32(4):390-7. PubMed ID: 6621374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteine-homocysteine mixed disulphide: differing plasma concentrations in normal men and women.
    Wilcken DE; Gupta VJ
    Clin Sci (Lond); 1979 Aug; 57(2):211-5. PubMed ID: 477256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status.
    Andersson A; Brattström L; Israelsson B; Isaksson A; Hamfelt A; Hultberg B
    Eur J Clin Invest; 1992 Feb; 22(2):79-87. PubMed ID: 1572391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between premenopausal women and young men in the transamination pathway of methionine catabolism, and the protection against vascular disease.
    Blom HJ; Boers GH; van den Elzen JP; van Roessel JJ; Trijbels JM; Tangerman A
    Eur J Clin Invest; 1988 Dec; 18(6):633-8. PubMed ID: 3147189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid responsive postmenopausal homocysteinemia.
    Brattström LE; Hultberg BL; Hardebo JE
    Metabolism; 1985 Nov; 34(11):1073-7. PubMed ID: 3932819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-related differences in methionine metabolism and plasma homocysteine concentrations.
    Fukagawa NK; Martin JM; Wurthmann A; Prue AH; Ebenstein D; O'Rourke B
    Am J Clin Nutr; 2000 Jul; 72(1):22-9. PubMed ID: 10871556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma homocysteine and menopausal status.
    Wouters MG; Moorrees MT; van der Mooren MJ; Blom HJ; Boers GH; Schellekens LA; Thomas CM; Eskes TK
    Eur J Clin Invest; 1995 Nov; 25(11):801-5. PubMed ID: 8582443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of sex and menopause on basal blood levels of homocysteine and after methionine loading].
    Reis RP; Azinheira J; Reis HP; Pina JE; Correia JM; Luís AS
    Rev Port Cardiol; 1999 Feb; 18(2):155-9. PubMed ID: 10221045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The homocysteinemia vascular risk factor. Methodologies and application to a clinical case].
    Garçon D; Barlatier A; Charpiot P; Calaf R; Joachim J; Perrin S; Habib M; Ambrosi P; Friggi A; Bodard H
    J Mal Vasc; 1991; 16(4):359-66. PubMed ID: 1791372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease.
    Fermo I; Vigano' D'Angelo S; Paroni R; Mazzola G; Calori G; D'Angelo A
    Ann Intern Med; 1995 Nov; 123(10):747-53. PubMed ID: 7574192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of mild hyperhomocysteinemia in vascular disease patients.
    Franken DG; Boers GH; Blom HJ; Trijbels FJ; Kloppenborg PW
    Arterioscler Thromb; 1994 Mar; 14(3):465-70. PubMed ID: 8123653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
    Ventura P; Panini R; Emiliani S; Salvioli G
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):44-51. PubMed ID: 14758571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease.
    Van den Berg M; Boers GH; Franken DG; Blom HJ; Van Kamp GJ; Jakobs C; Rauwerda JA; Kluft C; Stehouwert CD
    Eur J Clin Invest; 1995 Mar; 25(3):176-81. PubMed ID: 7781664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group.
    Verhoef P; Meleady R; Daly LE; Graham IM; Robinson K; Boers GH
    Eur Heart J; 1999 Sep; 20(17):1234-44. PubMed ID: 10454975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulphr containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide.
    Wilcken DE; Gupta VJ
    Eur J Clin Invest; 1979 Aug; 9(4):301-7. PubMed ID: 118020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of cysteine-homocysteine mixed disulphide in plasma of normal fasting man.
    Gupta VJ; Wilcken DE
    Eur J Clin Invest; 1978 Aug; 8(4):205-7. PubMed ID: 100323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine and thiol metabolites in vitamin B12 deficiency.
    Ranganath LR; Baines M; Roberts NB
    Clin Sci (Lond); 2001 Jan; 100(1):111-6. PubMed ID: 11115425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of coronary artery disease. A possible role for methionine metabolism.
    Wilcken DE; Wilcken B
    J Clin Invest; 1976 Apr; 57(4):1079-82. PubMed ID: 947949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease.
    Malinow MR; Kang SS; Taylor LM; Wong PW; Coull B; Inahara T; Mukerjee D; Sexton G; Upson B
    Circulation; 1989 Jun; 79(6):1180-8. PubMed ID: 2785871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.